Literature DB >> 19875170

Descemet's membrane endothelial keratoplasty: prospective multicenter study of visual and refractive outcomes and endothelial survival.

Marianne O Price1, Arthur W Giebel, Kelly M Fairchild, Francis W Price.   

Abstract

PURPOSE: To describe Descemet's membrane endothelial keratoplasty (DMEK) techniques, perioperative challenges, management, and visual and refractive outcomes.
DESIGN: Prospective, multicenter, consecutive case series. PARTICIPANTS: Sixty eyes of 56 patients with Fuchs' endothelial dystrophy, pseudophakic bullous keratopathy, or failed previous graft. INTERVENTION: Descemet's membrane (DM) and endothelium were stripped from donor corneas submerged in corneal storage solution in a corneal viewing chamber. Donor DM diameters were 8.5 or 9.0 mm. The central 7 mm of DM was stripped from the recipient cornea. After staining with trypan blue to improve visualization, donor DM was inserted through a 2.8-mm incision. Descemet's membrane endothelial keratoplasty was performed alone (n = 48) or was combined with phacoemulsification and lens implantation (n = 11), pars plana vitrectomy (n = 2), or both. MAIN OUTCOME MEASURES: Best spectacle-corrected visual acuity (BSCVA), manifest refraction, and endothelial cell density.
RESULTS: Median BSCVA was 20/30 at 1 month (range, 20/20-20/60), improving from 20/50 (range, 20/25-hand movements) before DMEK, excluding 4 eyes (7%) with preexisting ocular pathologic features that limited visual potential. At 3 months, 26% had 20/20 vision, 63% saw 20/25 or better, and 94% saw 20/40 or better. Refractive cylinder remained unchanged at 0.9 diopters (D; P = 0.93), and a hyperopic shift of 0.49+/-0.63 D (P = 0.0091) was noted in DMEK single procedures. Endothelial cell loss was 30%+/-20% at 3 months and 32%+/-20% in 38 eyes that reached the 6-month examination. Median pachymetry decreased from 660 mum before surgery to 530 mum. Descemet's membrane stripped successfully from 60 of 72 donor corneas; 6 were converted successfully to Descemet's stripping automated endothelial keratoplasty (DSAEK) and 6 (8%) were discarded. Only 1 graft detached completely, but air was reinjected in 38 eyes (63%), mainly for partial detachments. Five DMEK corneas (8%) failed to clear and were replaced successfully with DMEK or DSAEK. All remained clear at last follow-up.
CONCLUSIONS: Compared with DSAEK, DMEK provided a significantly higher rate of 20/20 and 20/25 vision, with comparable endothelial cell loss. Descemet's membrane endothelial keratoplasty restored physiologic pachymetry, but donor preparation and attachment currently are more challenging than with DSAEK.

Entities:  

Mesh:

Year:  2009        PMID: 19875170     DOI: 10.1016/j.ophtha.2009.07.010

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  112 in total

1.  "PI-less DMEK": results of Descemet's membrane endothelial keratoplasty (DMEK) without a peripheral iridotomy.

Authors:  Eitan Livny; Irit Bahar; Issac Levy; Michael Mimouni; Yoav Nahum
Journal:  Eye (Lond)       Date:  2018-12-05       Impact factor: 3.775

Review 2.  [DMEK: Descemet membrane endothelial keratoplasty].

Authors:  C Cursiefen; F E Kruse
Journal:  Ophthalmologe       Date:  2010-04       Impact factor: 1.059

Review 3.  [Complications of Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)].

Authors:  M A Thiel; F Bochmann; A Schmittinger-Zirm; P B Bänninger; M K Schmid; C Kaufmann
Journal:  Ophthalmologe       Date:  2015-12       Impact factor: 1.059

4.  [Refractive changes in triple Descemet membrane endothelial keratoplasty].

Authors:  C Girbardt; N Oertel; J Adamek-Dyk; P Wiedemann; A Nestler
Journal:  Ophthalmologe       Date:  2016-03       Impact factor: 1.059

5.  [Refractive changes after Descemet membrane endothelial keratoplasty].

Authors:  T Röck; K U Bartz-Schmidt; D Röck; E Yoeruek
Journal:  Ophthalmologe       Date:  2014       Impact factor: 1.059

6.  Activation of PINK1-Parkin-Mediated Mitophagy Degrades Mitochondrial Quality Control Proteins in Fuchs Endothelial Corneal Dystrophy.

Authors:  Takashi Miyai; Shivakumar Vasanth; Geetha Melangath; Neha Deshpande; Varun Kumar; Anne-Sophie Benischke; Yuming Chen; Marianne O Price; Francis W Price; Ula V Jurkunas
Journal:  Am J Pathol       Date:  2019-07-27       Impact factor: 4.307

7.  Negative impact of dextran in organ culture media for pre-stripped tissue preservation on DMEK (Descemet membrane endothelial keratoplasty) outcome.

Authors:  Alaadin Abdin; Loay Daas; Max Pattmöller; Shady Suffo; Achim Langenbucher; Berthold Seitz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-08-02       Impact factor: 3.117

8.  Aspiration of Tri-folded, Endothelium-In Grafts for Descemet Membrane Endothelial Keratoplasty.

Authors:  Sezen Karakus; Mehrnaz Ighani; Puntakarn Noparat; Marjan Tofigh; Eric Chiang; Kali Barnes; Conan Y Chen; Tiffany S Liu; Allen O Eghrari
Journal:  Cornea       Date:  2019-05       Impact factor: 2.651

9.  Evaluation of factors affecting visual acuity after Descemet stripping automated endothelial keratoplasty.

Authors:  Shiro Amano; Akira Setogawa; Kenji Inoue
Journal:  Jpn J Ophthalmol       Date:  2016-12-10       Impact factor: 2.447

10.  Intraocular pressure elevation and post-DMEK glaucoma following Descemet membrane endothelial keratoplasty.

Authors:  Anna-Karina B Maier; Tina Wolf; Enken Gundlach; Matthias K J Klamann; Johannes Gonnermann; Eckart Bertelmann; Antonia M Joussen; Necip Torun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-07       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.